Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
864 | 2915 | 50.7 | 95% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | MCL 1 | Author keyword | 84 | 35% | 7% | 192 |
2 | ABT 737 | Author keyword | 52 | 56% | 2% | 63 |
3 | BCL 2 FAMILY | Author keyword | 46 | 28% | 5% | 143 |
4 | BH3 ONLY | Author keyword | 45 | 69% | 1% | 38 |
5 | BH3 ONLY PROTEINS | Author keyword | 37 | 57% | 2% | 44 |
6 | BH3 | Author keyword | 33 | 58% | 1% | 38 |
7 | BH3 MIMETICS | Author keyword | 30 | 64% | 1% | 29 |
8 | OBATOCLAX | Author keyword | 29 | 66% | 1% | 27 |
9 | BH3 DOMAIN | Author keyword | 29 | 58% | 1% | 33 |
10 | BAK | Author keyword | 27 | 28% | 3% | 83 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | MCL 1 | 84 | 35% | 7% | 192 | Search MCL+1 | Search MCL+1 |
2 | ABT 737 | 52 | 56% | 2% | 63 | Search ABT+737 | Search ABT+737 |
3 | BCL 2 FAMILY | 46 | 28% | 5% | 143 | Search BCL+2+FAMILY | Search BCL+2+FAMILY |
4 | BH3 ONLY | 45 | 69% | 1% | 38 | Search BH3+ONLY | Search BH3+ONLY |
5 | BH3 ONLY PROTEINS | 37 | 57% | 2% | 44 | Search BH3+ONLY+PROTEINS | Search BH3+ONLY+PROTEINS |
6 | BH3 | 33 | 58% | 1% | 38 | Search BH3 | Search BH3 |
7 | BH3 MIMETICS | 30 | 64% | 1% | 29 | Search BH3+MIMETICS | Search BH3+MIMETICS |
8 | OBATOCLAX | 29 | 66% | 1% | 27 | Search OBATOCLAX | Search OBATOCLAX |
9 | BH3 DOMAIN | 29 | 58% | 1% | 33 | Search BH3+DOMAIN | Search BH3+DOMAIN |
10 | BAK | 27 | 28% | 3% | 83 | Search BAK | Search BAK |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BH3 ONLY PROTEINS | 317 | 52% | 15% | 431 |
2 | BH3 MIMETIC ABT 737 | 250 | 72% | 7% | 196 |
3 | BH3 DOMAINS | 231 | 74% | 6% | 169 |
4 | BH3 DOMAIN | 130 | 49% | 7% | 193 |
5 | X L | 106 | 53% | 5% | 142 |
6 | BCL XL | 83 | 20% | 13% | 382 |
7 | MCL 1 | 77 | 32% | 7% | 197 |
8 | BCL 2 FAMILY MEMBERS | 75 | 28% | 8% | 226 |
9 | BAX | 69 | 14% | 16% | 461 |
10 | CYTOCHROME C RELEASE | 66 | 11% | 19% | 557 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy | 2014 | 141 | 212 | 72% |
Small molecule Mcl-1 inhibitors for the treatment of cancer | 2015 | 12 | 84 | 85% |
The BCL-2 protein family: opposing activities that mediate cell death | 2008 | 1715 | 161 | 68% |
The Bcl-2 apoptotic switch in cancer development and therapy | 2007 | 856 | 133 | 60% |
Mitochondria in Apoptosis: Bcl-2 Family Members and Mitochondrial Dynamics | 2011 | 346 | 114 | 49% |
Many players in BCL-2 family affairs | 2014 | 31 | 94 | 72% |
Building blocks of the apoptotic pore: how Bax and Bak are activated and oligomerize during apoptosis | 2014 | 21 | 118 | 89% |
The BCL-2 Family Reunion | 2010 | 481 | 87 | 37% |
The pathophysiology of mitochondrial cell death | 2004 | 1715 | 38 | 39% |
How do BCL-2 proteins induce mitochondrial outer membrane permeabilization? | 2008 | 444 | 51 | 65% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | TEAM CELL SURVIVAL TUMOR ESC E BREAST CANC 8 | 12 | 86% | 0.2% | 6 |
2 | MOL GENET CANC | 11 | 34% | 0.9% | 27 |
3 | UMR601 | 8 | 70% | 0.2% | 7 |
4 | PROGRAM CANC CHEM BIOL | 4 | 28% | 0.4% | 13 |
5 | SERONO PHARMACEUT | 4 | 32% | 0.4% | 11 |
6 | PLATEFORME IMPACT | 4 | 75% | 0.1% | 3 |
7 | HOWARD HUGHES MED PATHOL | 3 | 37% | 0.2% | 7 |
8 | LINDE PROGRAM CANC CHEM BIOL | 3 | 45% | 0.2% | 5 |
9 | BIOGENOUEST RECH THER EUT | 2 | 67% | 0.1% | 2 |
10 | BIOL INNOVAT THER EUT LOCALLY AGG S CANC UNI | 2 | 67% | 0.1% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000189700 | TAT BH4//MOL CELLULAR SIGNALING//BIOEMERGENCES IBISA |
2 | 0.0000141549 | BCL 2//BCL 2 PROTEIN//BCL X |
3 | 0.0000122825 | MGDC//VERRUCARIN A//RADIAT TUMOR PHYSIOL |
4 | 0.0000115234 | BCL2L12//BCL2 FAMILY//G P ANICOLAOU ONCOL |
5 | 0.0000114737 | BIKDD//MITOCHONDRIAL CYTOCHROME C RELEASE//BAX OVEREXPRESSION |
6 | 0.0000086138 | APAF 1//CASPASE 2//RAIDD |
7 | 0.0000084874 | BNIP3//BCH DOMAIN//HGTD P |
8 | 0.0000078135 | PLATELET APOPTOSIS//COATED PLATELET//STUDY HUMAN OPERATOR PERFORMANCE |
9 | 0.0000071146 | APOPTOSIS INDUCING FACTOR//AIF//AMID |
10 | 0.0000066926 | HEMATOL ONCOLWINSHIP CANC//MICROTUBULE ACTIVE DRUGS//PHARMACOLRAMMELKAMP EDUC |